Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
First-line pembrolizumab + chemotherapy in Japanese patients with advanced/metastatic esophageal cancer from KEYNOTE-590.
Esophagus. 2022 Oct;19(4):683-692. doi: 10.1007/s10388-022-00920-x. Epub 2022 Jun 7.
Esophagus. 2022.
PMID: 35668304
Free PMC article.
Clinical Trial.
The safety and tolerability of epacadostat alone and in combination with pembrolizumab in patients with advanced solid tumors: results from a first-in-Japanese phase I study (KEYNOTE-434).
Doi T, Fujiwara Y, Shitara K, Shimizu T, Yonemori K, Matsubara N, Ohno I, Kogawa T, Naito Y, Leopold L, Munteanu M, Yatsuzuka N, Han SR, Samkari A, Yamamoto N.
Doi T, et al. Among authors: yatsuzuka n.
Invest New Drugs. 2021 Feb;39(1):152-162. doi: 10.1007/s10637-020-00942-1. Epub 2020 Jun 20.
Invest New Drugs. 2021.
PMID: 32564277
Clinical Trial.
Item in Clipboard
Second-line pembrolizumab versus chemotherapy in Japanese patients with advanced esophageal cancer: subgroup analysis from KEYNOTE-181.
Muro K, Kojima T, Moriwaki T, Kato K, Nagashima F, Kawakami H, Ishihara R, Ogata T, Satoh T, Iwakami K, Han S, Yatsuzuka N, Takami T, Bhagia P, Doi T.
Muro K, et al. Among authors: yatsuzuka n.
Esophagus. 2022 Jan;19(1):137-145. doi: 10.1007/s10388-021-00877-3. Epub 2021 Sep 30.
Esophagus. 2022.
PMID: 34591237
Free PMC article.
Clinical Trial.
Item in Clipboard
First-line pembrolizumab plus chemotherapy for advanced/metastatic esophageal cancer: 1-year extended follow-up in the Japanese subgroup of the phase 3 KEYNOTE-590 study.
Kato K, Kojima T, Hara H, Tsuji A, Yasui H, Muro K, Satoh T, Ogata T, Ishihara R, Goto M, Baba H, Nishina T, Han S, Iwakami K, Yatsuzuka N, Doi T.
Kato K, et al. Among authors: yatsuzuka n.
Esophagus. 2024 Apr 12. doi: 10.1007/s10388-024-01053-z. Online ahead of print.
Esophagus. 2024.
PMID: 38607538
Item in Clipboard
The combination of elbasvir and grazoprevir for the treatment of chronic HCV infection in Japanese patients: a randomized phase II/III study.
Kumada H, Suzuki Y, Karino Y, Chayama K, Kawada N, Okanoue T, Itoh Y, Mochida S, Toyoda H, Yoshiji H, Takaki S, Yatsuzuka N, Yodoya E, Iwasa T, Fujimoto G, Robertson MN, Black S, Caro L, Wahl J.
Kumada H, et al. Among authors: yatsuzuka n.
J Gastroenterol. 2017 Apr;52(4):520-533. doi: 10.1007/s00535-016-1285-y. Epub 2016 Nov 21.
J Gastroenterol. 2017.
PMID: 27873094
Free PMC article.
Clinical Trial.
Item in Clipboard
A phase I, randomized, placebo-controlled study of molnupiravir in healthy Japanese to support special approval in Japan to treat COVID-19.
Nakamura K, Fujimoto K, Hasegawa C, Aoki I, Yoshitsugu H, Ugai H, Yatsuzuka N, Tanaka Y, Furihata K, Maas BM, Wickremasingha PK, Duncan KE, Iwamoto M, Stoch SA, Uemura N.
Nakamura K, et al. Among authors: yatsuzuka n.
Clin Transl Sci. 2022 Nov;15(11):2697-2708. doi: 10.1111/cts.13395. Epub 2022 Sep 23.
Clin Transl Sci. 2022.
PMID: 36053806
Free PMC article.
Clinical Trial.
Item in Clipboard
Growth and differentiation of periodontal ligament-derived cells in serum-free defined culture.
Okamoto T, Yatsuzuka N, Tanaka Y, Kan M, Yamanaka T, Sakamoto A, Takata T, Akagawa Y, Sato GH, Sato JD, Takada K.
Okamoto T, et al. Among authors: yatsuzuka n.
In Vitro Cell Dev Biol Anim. 1997 Apr;33(4):302-9. doi: 10.1007/s11626-997-0051-0.
In Vitro Cell Dev Biol Anim. 1997.
PMID: 9156347
Item in Clipboard
Cite
Cite